In the previous article, we looked at some of the strongest-performing S&P 500 stocks of the past five years. This time, we are turning the list upside down and looking at companies that delivered some of the weakest share-price performance over roughly the same period.
What makes this list especially interesting is that these are not obscure penny stocks or dying companies nobody has heard of. It includes names such as Nike, PayPal, Moderna, Lululemon, Estée Lauder, and other businesses known by hundreds of millions of people.
Yet investors who bought at the wrong time around five years earlier could have been sitting on paper losses of 70%, 80%, or even more.
This comparison focuses on share-price performance rather than total return, so dividends are not included. The percentages reflect a snapshot from late July 2026, which means the exact figures can shift depending on the trading day used.
This is not a list of stocks to short, just as the previous ranking was not a list of stocks to buy. The purpose is to study why highly recognizable companies can still become terrible investments at the wrong price.
10. Baxter International - Roughly -68%
Baxter International is a major U.S. healthcare and medical-technology company, and its appearance on the list immediately demonstrates something important: a company does not need to disappear or go bankrupt for its stock to perform terribly.
Baxter's continuing operations still generated more than $11 billion in revenue in 2025. But during the same period, gross margin weakened, the company recorded goodwill impairment charges, and restructuring continued. In the fourth quarter, Baxter reported more than $1 billion in GAAP losses from continuing operations.
A stock can therefore collapse even while the business still generates substantial revenue. It may be enough for profitability to deteriorate, growth to disappoint, investors to lose confidence in the previous story, or the market to stop assigning the same valuation to future earnings.
Stock prices do not only reflect what a company is earning today. They also reflect what investors believe it will earn tomorrow.
9. Block - Roughly -69%
Block, formerly known as Square and now trading under the ticker XYZ, declined by roughly 69% over the five-year period.
The company owns businesses including Square, Cash App, and Afterpay. During the pandemic, digital payments, fintech, online commerce, crypto, and Cash App all became extremely popular narratives, and investors began pricing in extraordinary future growth.
The company did not need to collapse for the stock to fall dramatically. Reality only had to become less impressive than the future already embedded in the valuation.
Block is still not a dead business. Its multi-year financial plan projected 17% gross-profit growth for 2026. That illustrates one of the most important lessons on this entire list: a bad stock return does not automatically mean a bad company.
Sometimes the problem is simply that the stock was too expensive at the starting point.
8. Lululemon - Roughly -70%
Lululemon is another example of a powerful brand producing a painful stock-market outcome. The company is associated with premium sportswear, athleisure, strong brand loyalty, and a highly engaged customer community.
Its global revenue still increased 5% to $11.1 billion in 2025, so this was not a business in complete collapse. But the Americas business weakened, regional revenue declined 1%, comparable sales fell 3%, and annual operating margin dropped by 380 basis points.
In the first quarter of 2026, comparable sales in the Americas declined another 5%, operating income dropped 37%, and the company lowered its full-year outlook.
The lesson is simple: even an excellent brand can enter a slower-growth phase. If the market previously assumed that extraordinary growth would continue for years, normalization can be extremely painful for the stock.
7. Nike - Roughly -72%
Nike may be one of the most surprising names on the list. It remains one of the most recognizable sports brands in the world, associated with global athletes, sneaker culture, Air Force 1, and the “Just Do It” brand identity.
Yet over the period examined, the stock lost roughly 72%.
During fiscal 2026, total revenue was approximately flat and declined 2% on a currency-neutral basis. Nike Direct revenue fell 6%, Nike Brand Digital declined 12%, and weakness also appeared in Greater China and EMEA.
Nike's brand did not become 72% worse. Its products did not suddenly become useless. What changed were growth expectations, competition, sales channels, margins, and the valuation investors were willing to assign to the company's future.
A great company is not automatically a great investment at every price. Liking the business and liking the valuation are two separate decisions.
6. Estée Lauder - Roughly -73%
The Estée Lauder Companies owns a major global portfolio including Estée Lauder, Clinique, MAC, La Mer, Tom Ford Beauty, Jo Malone, and many other brands.
A significant part of its weakness was connected to Asian demand and the travel-retail business. Fiscal 2025 revenue declined 8%, Asia/Pacific revenue fell 21%, and Mainland China declined 6%.
There were signs of improvement afterward. During the first nine months of fiscal 2026, China returned to growth and margins improved.
That matters because this is a historical ranking. It does not mean every company on the list will continue falling indefinitely. Some may already be in the middle of a turnaround.
But a future recovery would not change the experience of an investor who bought at a much higher valuation several years earlier.
5. Align Technology - Roughly -73%
Align Technology, the company behind Invisalign clear aligners, produced another interesting contradiction. In 2025, it generated a record $4 billion in annual revenue, while clear-aligner volumes also reached record levels.
Yet the stock was still down more than 70% over five years.
The reason is that stock prices do not measure the absolute size of a company. They measure expectations relative to the price investors are paying.
Full-year 2025 revenue growth was only 0.9%, while restructuring and impairment charges also affected the business. Revenue growth improved to 6.2% in the first quarter of 2026, suggesting that conditions may be improving.
But five years earlier, investors were paying for a very different expected growth path.
A fantastic company can still become a terrible investment if the entry price assumes a future the business cannot realistically deliver.
4. The Trade Desk - Roughly -78%
The Trade Desk is especially interesting because not long ago it was widely regarded as one of the elite growth-stock stories in the market.
Programmatic advertising, connected TV, data, AI, and the open internet all created a highly attractive narrative. The company was still growing in 2025, generating $2.9 billion in revenue, up 18% year over year.
But the year before, growth had been 26%. In the first quarter of 2026, growth slowed further to 12%, adjusted EBITDA margin declined from 34% to 30%, and non-GAAP net income fell year over year.
This was not necessarily a story of a broken company. It was a story of the market changing from pricing in an extraordinary future to pricing in a merely very good one.
For an expensive growth stock, results do not necessarily have to become bad for the share price to collapse. They may only need to become less impressive than expected.
3. PayPal - Roughly -81%
PayPal was one of the most famous market collapses of the period. During the pandemic, online shopping expanded dramatically and PayPal appeared perfectly positioned for the shift toward digital payments and e-commerce.
The narrative included PayPal, Venmo, cashless payments, and accelerating online commerce. The stock price reflected enormous optimism.
Then the economy reopened, growth normalized, and competition continued increasing from Apple Pay, Google Pay, Shop Pay, traditional banks, card networks, and other fintech companies.
The market eventually concluded that PayPal could still be a strong business without being the unstoppable growth machine investors had priced in during 2021.
At its 2025 Investor Day, PayPal said it had returned to profitable growth in 2024 and was targeting faster transaction-margin growth again by 2027. The business did not disappear, and millions of merchants still use its products.
But investors who bought near the peak still had to live through a Drawdown of more than 80%.
It is not enough to be right about the company. You also have to be right enough about the price you pay for it.
2. Charter Communications - Roughly -82%
Charter Communications, better known to many Americans through its Spectrum brand, declined roughly 82%.
The company operates across broadband internet, cable television, and mobile services, but the U.S. broadband market has become increasingly competitive.
Fiber networks, fixed wireless, telecom companies, and other broadband technologies have all increased competitive pressure. In the fourth quarter of 2025, Charter lost 119,000 internet customers while continuing to invest heavily in infrastructure.
Charter also illustrates another important risk. Companies with large debt burdens and capital-intensive business models can become far more sensitive to higher interest rates than companies with very little debt.
Sometimes a stock does not collapse because of one single problem. Several pressures can reinforce each other: competition, changing technology, customer losses, heavy capital spending, debt, and changing investor expectations.
1. Moderna - Roughly -83%
Moderna may be the most dramatic story on the list.
During the COVID era, the company transformed from a relatively unknown biotech business into a globally recognized brand. Vaccine demand created extraordinary revenue and profits, and investors began pricing the company as if some of that extraordinary environment might persist.
In the second quarter of 2022, Moderna was still generating billions of dollars in COVID-vaccine revenue. One year later, total second-quarter revenue had fallen to $344 million from $4.7 billion.
By the first quarter of 2025, Moderna reported only $108 million in total revenue while producing nearly $1 billion in net losses.
The company has since pursued major cost reductions while continuing to invest in new mRNA products, but the key historical lesson remains the same.
Pandemic-level vaccine demand came from an extraordinary event. It was not a normal baseline.
When the temporary demand surge disappeared, the entire valuation story had to be rewritten.
What Do These Ten Stocks Have in Common?
On the surface, Baxter, Block, Lululemon, Nike, Estée Lauder, Align, The Trade Desk, PayPal, Charter, and Moderna have very little in common.
They operate across healthcare, fintech, fashion, beauty, advertising, telecommunications, and biotechnology.
Yet several patterns appear repeatedly.
- Expectations had previously become extremely high.
- Temporary trends were sometimes treated as permanent.
- Growth later slowed or normalized.
- Margins came under pressure.
- Competition intensified.
- Investors confused a good company with a good stock at the current valuation.
Pandemic e-commerce, digital payments, at-home spending, extraordinary vaccine demand, and extreme growth-stock valuations all created conditions that looked durable for a period but eventually normalized.
The Stock Is Not the Same Thing as the Company
This may be the single most important lesson from the entire ranking.
Nike can be an excellent company. PayPal can remain a useful and profitable business. Lululemon can maintain strong brand loyalty.
Their stocks can still be terrible investments at a particular price.
Imagine a house in a great location, excellent condition, and realistically worth around $500,000. If you can buy it for $400,000, the deal may be attractive. If someone asks $2 million, the house has not suddenly become worse; the price has become worse.
Stocks work in much the same way. Business quality and valuation are separate questions.
Why Buying at the Peak of Hype Can Be So Dangerous
The most dangerous moment can be when everything about a company appears perfect. Revenue is growing quickly, analysts are enthusiastic, social media is full of the stock, and the share price has already risen dramatically.
At that point, a large amount of good news may already be reflected in the valuation.
The correct question is no longer simply, “Is this a good company?” It becomes, “What kind of future am I already paying for at today's price?”
If the market expects 30% annual growth and the company later delivers 15%, the business may still be performing extremely well in absolute terms.
The stock can still fall dramatically because the performance was weaker than the expectations already embedded in the price.
A stock can collapse even when the business is still growing. Sometimes reality is not bad - expectations were simply too high.
Does an 80% Decline Automatically Make a Stock Cheap?
No. The same rule that applies to past winners also applies to past losers.
A stock should not be bought simply because it has already fallen dramatically.
If a stock declines from $100 to $20, it has lost 80%. If it then falls another 50%, the price moves from $20 to $10.
There is no mathematical rule preventing that from happening.
A stock does not automatically become cheap because it has fallen a lot, just as it does not automatically become expensive because it has risen a lot.
Price has to be compared with the quality, profitability, growth prospects, risks, balance sheet, and future cash flows of the underlying business.
Temporary Trends Can Create Permanent Investing Mistakes
Several stocks on the list benefited from exceptional conditions that investors initially treated as if they might continue indefinitely.
PayPal and Block benefited from extraordinary pandemic-era digital-payment and e-commerce trends. Moderna experienced a historic surge in vaccine demand. Consumer companies benefited from unusual spending patterns. High-growth stocks were assigned extremely aggressive valuations.
The problem was not necessarily that those trends were imaginary. They were very real.
The mistake was assuming that an extraordinary period represented a permanent new baseline.
Growth Can Be Good and Still Not Be Good Enough
The Trade Desk is one of the clearest examples of this principle. A company can still grow revenue by double digits and disappoint investors if the valuation assumed even faster growth.
This is why growth investing requires more than identifying companies with increasing sales or earnings.
Investors also need to understand what level of growth the current valuation already assumes. A company growing 15% can be an outstanding business while still being a poor investment if the market had priced it as though 30% growth would continue for years.
Expectations create the benchmark the company has to beat.
Debt and Capital Intensity Matter Too
Charter Communications shows another dimension that does not appear as clearly in companies such as Nike or Lululemon.
Debt and capital requirements can dramatically influence how a company responds to higher interest rates and changing competitive conditions.
Businesses that require continuous infrastructure spending while carrying significant debt can have less flexibility when financing becomes more expensive or revenue growth weakens.
That means evaluating a stock requires more than studying revenue and brand strength. Capital structure can become part of the investment thesis too.
Turnarounds Do Not Erase the Previous Drawdown
Several companies on the list showed signs of improvement by 2026. Estée Lauder saw renewed growth in China, Align reported improved revenue growth, PayPal described a return to profitable growth, and other businesses were actively restructuring.
That is important because historical losers do not necessarily remain losers forever.
A company can recover, improve margins, regain growth, or successfully restructure. But that future possibility does not change the experience of someone who paid an extreme valuation years earlier and then experienced a 70% or 80% Drawdown.
Historical performance and future opportunity are different questions.
Studying Losers Can Be More Valuable Than Studying Winners
Successful investments are easy to explain with hindsight. Nvidia went up because AI. Comfort Systems benefited from data-center infrastructure. Once the outcome is known, the story becomes clean and obvious.
Losers force more uncomfortable questions.
- What did investors misunderstand?
- Which trends were temporary?
- Where was valuation too high?
- Which competitive advantage weakened?
- Where did consumer behavior change?
- Why did growth slow?
- Which risks were underestimated?
- Were warning signs already visible before the decline?
Those questions can often teach more about investing than simply looking at a chart that already went up tenfold.
Three Dangerous Assumptions
Several recurring mistakes appear throughout the ranking.
The first is: “Everyone knows this company, so it must be a safe investment.” Brand recognition does not protect investors from paying too much.
The second is: “The stock has already fallen a lot, so it must be cheap.” A large decline says nothing by itself about valuation.
The third is: “The company is growing, so the stock has to rise.” A growing company can still disappoint if market expectations were even higher.
Investing therefore requires evaluating not only the business, but also price, expectations, risk, time horizon, and how closely the future eventually matches what investors assumed today.
Final Thoughts
The ten weakest-performing stocks in this five-year comparison show that recognizable brands and large companies are not automatically safe investments.
Baxter, Block, Lululemon, Nike, Estée Lauder, Align Technology, The Trade Desk, PayPal, Charter Communications, and Moderna operate in completely different industries, but the same themes appear repeatedly: high expectations, slowing growth, temporary trends, margin pressure, changing competition, and valuation compression.
The single biggest lesson may be that the company and the stock are not the same thing. A good business can become a bad investment if the entry price requires unrealistic future growth.
Similarly, a stock that has already fallen 80% is not automatically cheap. The only meaningful question is what the market price represents relative to the business you are actually buying.
Do not ask only whether the company is good. Ask what expectations are already included in the price - and what happens if reality turns out to be merely good instead of extraordinary.
If you would like to learn more about how we think about markets, risk, and systematic decision-making inside our own automated trading system, you can find educational material and observe how the system operates at SignalCrumbs.com .
Related posts
